Standard BioTools Inc. Acquisitions, Net of Cash Acquired
Standard BioTools Inc. (LAB) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-03-16
- Standard BioTools Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2021-12-31 was $0.00.
- Standard BioTools Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2021-09-30 was $0.00.
- Standard BioTools Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2021-06-30 was $0.00.
- Standard BioTools Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Standard BioTools Inc. payments to acquire businesses, net of cash acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Standard BioTools Inc. payments to acquire businesses, net of cash acquired for fiscal 2024 was $1.39M.
- Standard BioTools Inc. payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00.
- Standard BioTools Inc. payments to acquire businesses, net of cash acquired for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 1 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-16 | ||||
| 2024-12-31 | $1.39M 10-K · filed 2026-03-16 | ||||
| 2023-12-31 | $0.00 10-K · filed 2026-03-16 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-03-08 | $0.00 derived: sum of 3 quarters · filed 2022-03-08 | $0.00 10-K · filed 2022-03-08 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-08 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | $0.00 derived: sum of 3 quarters · filed 2022-03-08 | $0.00 derived: sum of 4 quarters · filed 2022-03-08 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | $0.00 derived: sum of 2 quarters · filed 2022-03-08 | $0.00 derived: sum of 3 quarters · filed 2022-03-08 | $0.00 derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-03-08 | $0.00 derived: sum of 3 quarters · filed 2022-03-08 | $5.15M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $5.15M 10-Q · filed 2021-11-09 | $5.15M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $5.15M 10-Q · filed 2021-08-06 | $5.15M derived: sum of 3 quarters · filed 2022-03-08 | $5.15M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-03-31 | $5.15M 10-Q · filed 2021-05-07 | $5.15M derived: sum of 2 quarters · filed 2022-03-08 | $5.15M derived: sum of 3 quarters · filed 2022-03-08 | $5.15M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-03-08 | $0.00 derived: sum of 3 quarters · filed 2022-03-08 | $0.00 10-K · filed 2022-03-08 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $0.00 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 | ||||
| 2016-12-31 | $0.00 10-K · filed 2017-03-03 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $0.00 derived: sum of 2 quarters · filed 2017-03-03 | $0.00 derived: sum of 3 quarters · filed 2017-03-03 | $0.00 10-K · filed 2017-03-03 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | $0.00 derived: sum of 3 quarters · filed 2017-03-03 | $0.00 derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2017-03-03 | $0.00 derived: sum of 3 quarters · filed 2017-03-03 | $0.00 derived: sum of 4 quarters · filed 2017-03-03 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $0.00 derived: sum of 2 quarters · filed 2017-03-03 | $0.00 derived: sum of 3 quarters · filed 2017-03-03 | $113.19M 10-K · filed 2017-03-03 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $113.19M 10-Q · filed 2015-11-09 | $113.19M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $113.19M 10-Q · filed 2015-08-10 | $113.19M derived: sum of 3 quarters · filed 2016-02-29 | $113.19M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $113.19M 10-Q · filed 2015-05-11 | $113.19M derived: sum of 2 quarters · filed 2016-02-29 | $113.19M derived: sum of 3 quarters · filed 2016-02-29 | $113.19M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-02-28 | $113.20M 10-K · filed 2018-03-08 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $0.00 10-Q · filed 2014-08-04 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |